Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 11.98% is 256% above its 5-year average of -7.68%, near the high end of its 5-year range (-32.78%–17.81%).
As of the fiscal period ended Wednesday, December 31, 2025. 7.83% above its 12-month average of 11.11%.
Annual fiscal-year return on assets; no daily interpolation.
RETURN ON ASSETS (ROA)
11.98%
RETURN ON ASSETS (ROA) AVG TTM
11.11%
RETURN ON ASSETS (ROA) AVG 3Y
1.40%
RETURN ON ASSETS (ROA) AVG 5Y
-7.68%
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
+7.83%
CURRENT VS 3Y AVG
+754.19%
CURRENT VS 5Y AVG
+255.99%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
4.97%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
+141.05%
vs the sector median at left
TransMedics Group, Inc.
Market Cap
$2.79B
Return on Assets (ROA)
11.98%
TTM Avg
11.11%
3Y Avg
1.40%
5Y Avg
-7.68%
Market Cap
$2.86B
Return on Assets (ROA)
-12.01%
TTM Avg
-13.41%
3Y Avg
-10.26%
5Y Avg
-6.23%
Market Cap
$1.22B
Return on Assets (ROA)
-6.43%
TTM Avg
-17.46%
3Y Avg
-82.63%
5Y Avg
-55.94%
Market Cap
$470.55M
Return on Assets (ROA)
-27.49%
TTM Avg
-30.00%
3Y Avg
-27.77%
5Y Avg
-27.77%
Market Cap
$441.49M
Return on Assets (ROA)
4.30%
TTM Avg
13.65%
3Y Avg
19.24%
5Y Avg
21.45%
Market Cap
$15.31M
Return on Assets (ROA)
-163.04%
TTM Avg
-172.19%
3Y Avg
-99.08%
5Y Avg
-83.15%
Market Cap
$7.17B
Return on Assets (ROA)
-0.58%
TTM Avg
11.88%
3Y Avg
0.12%
5Y Avg
-6.73%
Market Cap
$7.88B
Return on Assets (ROA)
-0.42%
TTM Avg
-3.24%
3Y Avg
-6.85%
5Y Avg
-10.42%
Market Cap
$8.24B
Return on Assets (ROA)
-10.75%
TTM Avg
-43.49%
3Y Avg
-42.71%
5Y Avg
-41.26%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| TransMedics Group, Inc. (TMDX) | $2.79B | 11.98% | 11.11% | 1.40% | -7.68% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.86B | -12.01% | -13.41% | -10.26% | -6.23% |
| Teladoc Health, Inc. (TDOC)vs › | $1.22B | -6.43% | -17.46% | -82.63% | -55.94% |
| Shoulder Innovations, Inc. (SI)vs › | $470.55M | -27.49% | -30.00% | -27.77% | -27.77% |
| NRC Health (NRC)vs › | $441.49M | 4.30% | 13.65% | 19.24% | 21.45% |
| 23andMe Holding Co. (ME)vs › | $15.31M | -163.04% | -172.19% | -99.08% | -83.15% |
| Hims & Hers Health, Inc. (HIMS)vs › | $7.17B | -0.58% | 11.88% | 0.12% | -6.73% |
| Oscar Health, Inc. (OSCR)vs › | $7.88B | -0.42% | -3.24% | -6.85% | -10.42% |
| Tempus AI, Inc. (TEM)vs › | $8.24B | -10.75% | -43.49% | -42.71% | -41.26% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $8.99B | 1.72% | -6.26% | -11.14% | 1.46% |
ROA
12.0%
ROE
34.8%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 17.81% |
| 2024-12-31 | 4.41% |
| 2023-12-31 | -3.54% |
| 2022-12-31 | -13.07% |
| 2021-12-31 | -32.78% |
| 2020-12-31 | -18.91% |
| 2019-12-31 | -31.86% |
| 2018-12-31 | -56.35% |
| 2017-12-31 | -56.28% |
| 2016-12-31 | -41.42% |
